V-Shield
Vaccines can be unpredictable, especially when produced under rapid development. Moreover, coronaviruses can quickly adapt to antibody based treatments. Our exclusive V-shield technology provides safe antiviral protection that coronaviruses cannot easily evade.
In-Vitro testing shows Covid-19 viral inhibition with
V-Shield
Our V-Shield anti-viral therapy is demonstrating promising results in early preclinical tests.
Research and Development
V-Shield
Flu and coronavirus therapy
Betagen
Type -1 diabetes therapy
Christall Technologies leverages the power of bioflavonoids to treat a variety of ailments. Our delivery systems allow for optimal plasma concentrations that yield powerful efficacy and low toxicity.
About us
Small Molecules
In order to fight the current Covid-19 pandemic, we have developed a cocktail of small molecules that block the SARS-CoV-2 virus from entering it's host cell while simultaneously disrupting it's viral membrane and downregulating the excessive production of interleukins which driver respiratory failure.
